Robust Postmortem Survival of Murine Vestibular and Cochlear Stem Cells
- First Online:
- Cite this article as:
- Senn, P., Oshima, K., Teo, D. et al. JARO (2007) 8: 194. doi:10.1007/s10162-007-0079-6
Potential treatment strategies of neurodegenerative and other diseases with stem cells derived from nonembryonic tissues are much less subjected to ethical criticism than embryonic stem cell-based approaches. Here we report the isolation of inner ear stem cells, which may be useful in cell replacement therapies for hearing loss, after protracted postmortem intervals. We found that neonatal murine inner ear tissues, including vestibular and cochlear sensory epithelia, display remarkably robust cellular survival, even 10 days postmortem. Similarly, isolation of sphere-forming stem cells was possible up to 10 days postmortem. We detected no difference in the proliferation and differentiation potential between stem cells isolated directly after death and up to 5 days postmortem. At longer postmortem intervals, we observed that the potency of sphere-derived cells to spontaneously differentiate into mature cell types diminishes prior to the cells losing their potential for self-renewal. Three-week-old mice also displayed sphere-forming stem cells in all inner ear tissues investigated up to 5 days postmortem. In summary, our results demonstrate that postmortem murine inner ear tissue is suited for isolation of stem cells.
Keywordsutricle hair cell regeneration spiral ganglion neurosphere
The inability of the cochlea to replace lost hair cells is the major reason for the irreversibility of hearing loss in mammals. A starting point for a potential cure for hearing loss would be to regenerate hair cells either by transplantation of replacement cells or by stimulating cells of the damaged inner ear sensory epithelia to proliferate and to differentiate into hair cells.
Cells with the capacity to proliferate and to differentiate into hair cells and other cell types have been isolated from the murine vestibular system (Li et al. 2003a) and, more recently, from cochlear tissues such as the organ of Corti and the spiral ganglion (Oshima et al. 2007). These proliferative cells have the ability to form floating colonies, so-called spheres, when grown in nonadherent conditions. Furthermore, the spheres can be propagated for multiple generations, which is an indication that they are generated from self-renewing stem cells, very similar to neurospheres that grow from neural stem cells (McKay 1997). Regardless of the remarkable plasticity of neural stem cells, inner ear-derived stem cells and their derivatives are probably most suitable for use in transplantation experiments to replace lost hair cells because the inner ear-derived spheres contain cells that readily differentiate into hair cell-like cells in vitro and in vivo (Li et al. 2004a). One of the major obstacles that stem cell transplantation technology must overcome to repair damaged mammalian cochleae is the generation of hair cells in the organ of Corti in vivo, and despite some observations of neural stem cell survival and occasional expression of hair cell markers (Fujino et al. 2004; Parker and Cotanche 2004; Tateya et al. 2003), no robust regimen has been developed hitherto that allows the study of functional replacement of lost hair cells with stem cells. Nevertheless, the development of new surgical procedures and the exploration of stem cell types other than neural stem cells will hopefully result in more studies toward determining the potential of cochlear stem cell therapy.
A second major obstacle is the lack of a source of appropriate human stem cells for transplantation experiments into the cochlea and potential future therapy. Human embryonic stem cells could be such a source but are subjected to ethical criticism. Stem cells isolated from the human inner ear, on the other hand, could serve as a source without ethical constraints. Current research on this topic focuses on human inner ear tissue that is removed during infrequent inner ear surgery (Rask-Andersen et al. 2005). This strategy is hampered by the fact that surgically removed tissue is taken from patients with inner ear disease.
Toward exploring new sources for mammalian inner ear stem cells, we performed a pilot study in newborn mice to assess viability and features of cochlear and vestibular stem cells as a function of the postmortem interval, which could determine reasonable time limits for harvesting human inner ear tissues from autopsy cases in the future. Our results show that stem cells in the inner ear of newborn mice are detectable, alive, and functional up to 240 h after death. We therefore hypothesize that it should be possible to harvest human inner ear stem cells from autopsy cases, at least within the first few days postmortem. Although the therapeutic value of inner ear stem cells has not been determined, we propose that new sources, particularly for human inner ear stem cells, will advance the development of novel treatment strategies of inner ear diseases.
MATERIAL AND METHODS
Newborn (P1/P2) or 3-week-old (P21) Math-1/nuclear green fluorescence protein (nGFP) mice (Lumpkin et al. 2003) were euthanatized by CO2 overdose. To ensure death, we exposed the animals to 100% CO2 for 2 h, which is more than twice the maximum time to death reported for newborn neonatal mice with this procedure (Pritchett et al. 2005). Death was confirmed by absence of respiration, cessation of heartbeat, lack of reflexes, and loss of bladder control. Inner ear tissues were either dissected immediately postmortem or stored for 6 h at room temperature followed by storage at 4°C for later dissection. This storage scenario was chosen to simulate the conditions found in human autopsy cases. The study was performed with newborn and 3-week-old mice because we wanted to be able to investigate the postmortem features of all inner ear tissues, including the cochlea. Cochlear stem cells exist but are scarce in adult animals (Oshima et al. 2007). Postmortem intervals are defined as immediately after the CO2 exposure and decapitation = 0 h, after 6 h room temperature = 6 h, and storage at 4°C for 1, 2, 3, 4, 5, 10, and 15 days. Animal studies were conducted under an approved institutional protocol according to National Institutes of Health guidelines.
Isolation of inner ear stem cells and sphere formation
Sphere formation was initiated by adding 2 ml DMEM/high-glucose and F12 media (mixed 1:1) supplemented with N2 and B27 supplements (Invitrogen), EGF (20 ng/ml), basic fibroblast growth factor (bFGF) (10 ng/ml), insulin-like growth factor-1 (IGF-1) (50 ng/ml), and heparan sulfate (50 ng/ml) (all growth factors were obtained from R&D Systems, Minneapolis, MN, USA, and Sigma, St. Louis, MO, USA). The diluted suspension was then passed through a 70-μm cell strainer (BD Labware, San Jose, CA, USA) directly into plastic Petri dishes (Greiner, Monroe, NC, USA), resulting in a single cell solution virtually devoid of large cell aggregates. Routinely, we plated the total yield of single cells that we obtained from the two inner ear organs of a single mouse into one Petri dish (Greiner Bio-One, suspension culture plate). The total numbers of primary spheres were assessed after 7 days in culture in a humidified incubator at 37°C and 5% CO2.
Five percent (10 μl) of the undiluted cell suspension was used for determination of cell numbers immediately after dissection and trituration. The numbers of living and dead cells were assessed using a hemacytometer (Neubauer improved) after adding 10 μl of a 0.4% solution of trypan blue (Invitrogen) to the single cell solution. Exclusion of the dye from living cells allowed us to determine the absolute and relative number of dead vs living cells.
Due to the frailness of the tissues at later postmortem stages, we had to modify our previously published dissection protocol (Oshima et al. 2007). Oshima et al. dissected the inner ear in a dish with Hanks’ solution and transferred the cleaned inner ear organs into a drop of PBS before adding trypsin. In the present protocol, we dissected and cleaned the inner ear organs directly in a small drop of PBS before adding trypsin to the same drop. Using this method, we made sure that we did not lose frail inner ear tissues during the cleaning step. We believe that this method may lead to an increase in the number of cells from surrounding tissue, which remain swimming in the drop. Therefore, cell numbers per specimen cannot be directly compared to the numbers published by Oshima et al. (2007). Additionally, we also would like to note that we present sphere numbers as spheres per 104 living cells as compared to earlier papers from our laboratory, which reported sphere numbers per 104 total cells (Li et al. 2003a; Oshima et al. 2007).
Stem cell propagation
Spheres derived from spiral ganglia were propagated by dispersing 30–50 spheres with a 5-min Accumax (Innovative Cell Technologies, San Diego, CA, USA) treatment at 37°C followed by careful trituration using a fire-polished glass pipette. In contrast, utricular and organ of Corti-derived spheres were mechanically dissociated after treatment with Accumax for 9 min at 37°C. Accumax activity was blocked by diluting the cell suspension with media. The cell suspensions were replated into DMEM/high-glucose and F12 media (mixed 1:1) supplemented with N2 and B27 supplements (Invitrogen), EGF (20 ng/ml), bFGF (10 ng/ml), IGF-1 (50 ng/ml), and heparan sulfate (50 ng/ml) (growth factors and heparan sulfate were obtained from Sigma) in Petri dishes and propagation was repeated at 5-day intervals. Fresh growth factors were added daily from stock solutions. For long-term propagation, we counted the number of spheres for each generation, related the number to the original sphere number, and replated half of the spheres for producing the next generation.
Second- or third-generation spheres were plated onto fibronectin-coated Lab-Tek®II slides (Chamber Slide™ system, Nalge Nunc International, Rochester, NY, USA) in DMEM/high glucose and F12 medium (mixed 1:1) supplemented with N2 and B27 supplements. Eighty percent of the medium was replaced twice a week. Differentiated cells were analyzed after 14 days by immunocytochemistry.
The attached cells were fixed for 5 min with 4% paraformaldehyde in PBS and washed with PBS, and nonspecific binding sites were blocked for 1 h in 0.1% Triton-100, 1% bovine serum albumin (BSA) (wt/vol), and 5% (wt/vol) heat-inactivated goat serum in PBS (PBT1). The slides were incubated overnight at 4°C in PBT1 with diluted antibodies: 1:1,000 for polyclonal guinea pig antibody to murine myosin activated factor VII (VIIA) (Oshima et al. 2007), 1:2,000 for polyclonal rabbit antibody to parvalbumin 3 (Heller et al. 2002), 1:3,000 for polyclonal antibody to espin (Li et al. 2004b), 1:500 for polyclonal antibody to glial fibrillary acidic protein (GFAP; Dako, Glostrup, Denmark), and 1:500 for monoclonal mouse antibody to neuron-specific β-III tubulin (TuJ; Covance, Princeton, NJ, USA). Cy5-, tetramethyl rhodamine iso-thiocyanate-, and flourescein isothiocyanate-conjugated secondary antibodies (Jackson Immuno Research, West Grove, PA, USA) were diluted 1:400 in 0.1% Triton-100 and 0.1% BSA (wt/vol) in PBS and used to detect primary antibodies. 4′,6-Diamidino-2-phenylindole dihydrochloride (DAPI; Invitrogen) was used to visualize nuclei. The slides were analyzed using an epifluorescence microscope equipped with digital camera and image acquisition software (Zeiss Axio Imager with AxioCam HR and AxioVision 4.0 running on a Fujitsu-Siemens PC).
Temporal bones were dissected and the otic capsule was opened by drilling a small opening at the helicotrema and by removing the stapes footplate. After fixation overnight with 4% paraformaldehyde in PBS, the specimens were washed with PBS, soaked in 15% sucrose (wt/vol) in PBS for 6 h, and transferred to a 30% sucrose (wt/vol) solution in which they remained overnight at 4°C. The cryoprotected specimens were then embedded in OCT compound (Tissue-Tek, Sakura Finetek, Torrance, CA, USA), frozen at −20°C, and cryosectioned with a thickness of 12–16 μm (CM3050S cryostat, Leica, Wetzlar, Germany). The slides were incubated overnight with diluted primary antibodies that were visualized with fluorescent dye-conjugated secondary antibodies as described in the preceding section. Rhodamine-conjugated phalloidin (Invitrogen) was used to stain filamentous actin and DAPI was used to visualize nuclei. The specimens were examined and documented with an epifluorescence microscope as described above.
Morphology and cell survival in postmortem inner ear tissues
Sphere formation as a function of the postmortem interval
Generally, the utricle yielded lower numbers of sphere-forming cells per 104 cells than the organ of Corti and the spiral ganglion. The number of spheres per 104 living cells from the utricle was 91.6 ± 14.9 (mean ± SEM; n = 3) directly after death and did not change significantly during the first 4 days postmortem. At 5 and 10 days postmortem, the utricle had lost about 60% of its ability to give rise to spheres and only one single sphere in three independent experiments was generated from 15-day-postmortem utricular cells. In both the organ of Corti and the spiral ganglion, we noted a higher incidence of sphere-forming cells than in the utricle [168.5 ± 5.4 and 211.8 ± 18.2 (mean ± SEM; n = 3) spheres per 104 living cells, respectively] and increasing numbers of sphere-forming cells during the first 24 h after death (Fig. 4A). Similar to the utricle, the organ of Corti and the spiral ganglion displayed reduced ability to generate spheres after 5 and 10 days postmortem. Only occasionally did we observe formation of spheres with cells isolated at day 15 postmortem: in two of three cases, we found a single sphere after plating 104 cells of a cell suspension prepared from day-15-postmortem organs of Corti. Interestingly, we found a tendency for higher sphere numbers in organ of Corti and spiral ganglion tissues harvested at 6 h and 1 day postmortem when compared with those harvested immediately postmortem. We hypothesize that postmortem-related changes in the dying tissue, such as hypoxia, acidosis, and lack of nutrients, may stimulate or positively select stem cells over other tissue cells.
We have previously shown that utricle-derived spheres can form from single cells (Li et al. 2003a). Using flow cytometry, we verified that organ of Corti-derived solid spheres also form from single cells with an incidence of 30 spheres per 104 cells. This number is smaller than the number we obtained when plating the cells at low density, which is an indication that inner ear stem cells are sensitive to the flow cytometry procedure or that some spheres in our experiments may start out as small cell aggregates.
The apparent postmortem changes in the numbers of spheres per 104 cells led us to investigate whether spheres derived at different postmortem periods differed in their growth potential. A simple measure of a sphere’s growth potential is its diameter at a fixed time after plating. We found that the diameters of solid spheres of all three inner ear organs did not significantly change when compared at different postmortem intervals (Fig. 4B). The diameters of utricle-derived spheres ranged from 28.4 ± 2.9 to 37.5 ± 3.3 μm (mean ± SEM; n = 3), organ of Corti-derived spheres ranged from 35.7 ± 3.4 μm to 45.7 ± 4.2 μm (mean ± SEM; n = 3), and spiral ganglion-derived spheres ranged from 35.1 ± 2.9 to 46.2 ± 4.9 μm (mean ± SEM; n = 3).
The self-renewal capacity of inner ear stem cells does not change postmortem
Spheres derived from postmortem tissues give rise to mature inner ear cell types but lose the ability to generate differentiated cells after protracted postmortem intervals
Sphere-forming stem cells isolated from the adult mouse utricle are capable of differentiating into several different cell types, including hair cell-like cells and neurons (Li et al. 2003a). This multipotency is also characteristic of organ of Corti- and spiral ganglion-derived stem cells because organ of Corti-derived stem cells can be differentiated into hair-like cells and supporting cells and spiral ganglion-derived stem cells into neurons and cells that express glial markers (Oshima et al. 2007). We were interested in exploring whether stem cells isolated after protracted postmortem intervals remain multipotent and whether their potency to generate hair cell marker-expressing cells and neurons remains stable when compared with stem cells isolated directly after death of the animal. Robust maintenance of multipotency after prolonged postmortem intervals would be a desirable feature, particularly for planned future tests with human inner ear tissue.
Spheres from postmortem tissues of older mice
A prospective goal of our research is to explore the merit of potential human inner ear stem cells. Because our study was conducted with neonatal mice, one could argue that our results are not directly comparable with the human situation where postmortem tissue will likely be obtained from adults. Conversely, the use of neonatal mice allowed us to investigate the postmortem survival of cochlear stem cells, which are rarely found in adult mice (Oshima et al. 2007).
To show that sphere-forming stem cells are also present in the postmortem inner ear of older mice, we chose three-week-old (P21) mice because, at this age, sphere-forming stem cells can be isolated from vestibular and cochlear parts of the inner ear (Oshima et al. 2007). We found that the P21 utricle harbors 13.5 ± 1.2 (mean ± SEM; n = 3) sphere-forming cells per 104 living cells 0 h postmortem, 5.9 ± 1.3 sphere-forming cells at 3 days postmortem, and 0.71 ± 0.24 sphere-forming cells at 5 days postmortem. In the organ of Corti, we found 2.1 ± 0.3 sphere-forming cells per 104 living cells 0 h postmortem, 0.5 ± 0.1 sphere-forming cells at 3 days, and 0.2 ± 0.1 sphere-forming cells at 5 days postmortem. Finally, in the spiral ganglion, we found 2.4 ± 0.2 sphere-forming cells per 104 living cells 0 h postmortem, 1.1 ± 0.1 sphere-forming cells at 3 days postmortem, and 0.2 ± 0.1 sphere-forming cells at 5 days postmortem. Our 0-h-postmortem numbers are comparable with previous results, although the methods used for stem cell isolation were, to some extent, different (Oshima et al. 2007).
The main conclusion that we draw from our study is that inner ear stem cells are surprisingly robust and survive in reasonable numbers even after protracted postmortem time intervals. We were able to routinely isolate sphere-forming stem cells from vestibular and auditory sensory epithelia and from the spiral ganglion until 10 days postmortem. To demonstrate the self-renewal capacity and potency of inner ear stem cells, we propagated the spheres and tested second- and third-generation spheres for their ability to generate inner ear cell types defined by hair cell and neuronal marker expression. As expected (Li et al. 2003a; Oshima et al. 2007), sensory epithelium-derived spheres readily gave rise to hair cells and other cell types such as neurons (data not shown, but see Li et al. 2003a; Oshima et al. 2007), whereas spiral ganglion-derived neurospheres served as a potent source for neurons and glial cell types, but not for hair cells. This capacity of the different sphere types was determined by spontaneous differentiation in serum-free culture and we consider that the true potential of the different inner ear-derived spheres is higher when the cells are exposed to different environments. This hypothesis is supported by our previous finding that utricle-derived sphere-forming stem cells display pluripotency after grafting into a gastrulating embryo (Li et al. 2003a). Nevertheless, we also observed changes in the spheres derived from 10-day-postmortem tissues. Utricle-derived spheres lost their ability to attach to the fibronectin substrate that we used in our experiments and spiral ganglion-derived spheres lost their ability for neural differentiation. These observations suggest that significant molecular changes happen after death that affect the potency of the sphere-forming utricle and spiral ganglion stem cells and their derivatives. Conversely, organ of Corti-derived sphere-forming stem cells did not show reduced potency to generate hair cell marker-positive cells, even after 10 days postmortem. We observed, however, a much higher interexperimental variability when quantifying hair cell marker-positive cells from 10-day-postmortem organ of Corti spheres. In addition, we also experienced a reduced ability of these spheres to attach to the fibronectin substrate (data not shown), which indicates that the progenitor and stem cells in these spheres likely undergo similar diminishing changes when compared with the 10-day-postmortem spheres from utricle and spiral ganglia, but with some delay.
It is remarkable that spheres generated from 5-day-postmortem tissues were virtually indistinguishable from spheres generated from tissues isolated directly after death. We did not detect any quantitative differences in the growth potential or in the ability to generate specific cell types. Postmortem changes in the sphere-forming cells appear to first reduce the cells’ potency to differentiate into mature cell types before affecting the stem cells’ growth potential. An explanation for this change in the cells’ ability could be that their restricted potency between postmortem days 5 and 10 is a result of a fallback into a less committed mode, which would require additional signals to initiate specific cell differentiation.
Stem cells after death
Organ donation is a widely utilized and an obvious strategy to obtain organs for transplantation to treat heart, kidney, lung, and liver disease, among others. Some organs, such as the cornea and the middle ear ossicles, are removed postmortem and reused for allografting. It has been shown previously that split-thickness skin grafts can be allografted up to 3 weeks after death if stored at 4°C (Rosenquist et al. 1988), a fact that supports our results with surviving cells in the inner ear up to 15 days postmortem. More recently, stem and progenitor cells have been isolated from postmortem brain, spinal cord, and the retina (Laywell et al. 1999; Mayer et al. 2005; Palmer et al. 2001; Roisen et al. 2001). Generally, it appears that many stem cells survive for hours or even days after death, but no study thus far has systematically and quantitatively investigated the postmortem time course of the decrease in stem cell numbers and the specific potential of stem cells isolated at different postmortem time intervals. Moreover, we observed an increase in sphere numbers from organ of Corti and spiral ganglion after 6 h and 1 day postmortem (Fig. 4A), and we speculate that hypoxia, acidosis, or lack of nutrients and other postmortem-related factors may contribute to a stimulation or positive selection of stem cells over other cells in dying tissue. This stem cell activation may be the result of an effort to repair local tissue damage.
Our results show that it is possible to isolate sphere-forming stem cells not only from neonatal animals, but also from older mice (P21). This evidence spurs our confidence that the isolation of sphere-forming cells from the postmortem human inner ear will be a feasible endeavor in the near future. Nevertheless, we observed a reduction in the number of spheres generated from inner ear tissues of 3-week-old mice when we compared sphere formation directly following death with sphere formation at 3 and 5 days postmortem. From this observation, we conclude that the isolation of adult inner ear stem cells at protracted postmortem intervals is probably more challenging than the isolation of inner ear stem cells from neonatal mice. Another sobering fact is that, in murine inner ear, stem cells can only be robustly isolated from the vestibular system (Oshima et al. 2007) and just sporadically occurred from cochlear tissues. If these facts are broadly applicable to adult human inner ear tissues, we expect that isolation of stem cells from the vestibular system will be more straightforward than from cochlear tissues. However, a recent study has reported the isolation of sphere forming stem cells from the spiral ganglion of adult humans and guinea pigs (Rask-Andersen et al. 2005), which might point to an inherent difference between mice and humans or guinea pigs. Alternatively, this difference might be caused by procedural differences in cell isolation and/or handling. Our own observations indicate that small procedural changes have substantial impact on the efficiency of stem cell isolation, which lead us to expect that future studies will improve on the isolation procedures of different types of inner ear stem cells. We are therefore optimistic that it will be possible to routinely isolate stem cells from adult human vestibular tissue and possibly also from cochlear tissues.
The authors thank the members of our group, particularly Anthony Peng and Eva Clamann, for valuable discussions and for suggestions on the manuscript. Begun at the Massachusetts Eye & Ear Infirmary, this work was supported in part by grants PBBEB-105075 (2005) and 1226/PASMA-111607/1 (2006) from the Swiss National Science Foundation to P.S., by a McKnight Endowment Fund for Neuroscience Brain Disorders Award and grants from the National Institutes of Health DC006167 and DC007132 to S.H.